MESO-Rx is pleased to announce the release of a new article detailing a medically-supervised dosing protocol for EPO. This comprehensive piece focuses on an 88-page study protocol developed by university researchers, addressing both potential performance benefits and associated health risks.
https://thinksteroids.com/articles/medically-supervised-epo-dosing-protocol-study/
https://thinksteroids.com/articles/medically-supervised-epo-dosing-protocol-study/
